Novartis recalls immunosuppressant Sandimmune, Neoral capsules for hazardous packaging

Novartis, like many generic drugmakers, was forced to pull copies of generic Zantac off shelves late last year after a carcinogen scare shocked the industry. Now, it's once again pulling products off shelves—and this time, it's two branded drugs whose packaging has proved hazardous to children.